drugset / Trial / NCT00989937

Oxytocin Add-on Study for Stable Anxiety Patients

NCT00989937 ↗

Terminated 17 enrolled University of California, San Diego
RandomizedCrossoverTriple-blindTreatment

Summary

The objective of the study is to compare the efficacy of intranasal oxytocin versus intranasal placebo to improve anxiety symptoms in patients with a variety of anxiety disorders.

Timeline

Start
2009-02
Primary completion
2011-04
Completion
2011-04

Outcome

Outcome not reported

Stopped (Business): “Break in funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 40 iu Intranasal

Indications